Decipher Labs (BOM:524752) ROC %: 1.50% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524752 Decipher Labs Ltd BOM:524752
57 GF Score
Price ₹6.29
GF Value ₹6.34
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Decipher Labs ROC %?

Decipher Labs BOM:524752 -4.70% 57 ROC % is 1.50% as of Mar. 2026. GuruFocus rates BOM:524752 with a GF Score™ of 57/100 and a GF Value™ of ₹6.34 (Fairly Valued). The stock has 3 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Decipher Labs's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 1.50%.

As of today (2026-07-20), Decipher Labs's WACC % is 17.83%. Decipher Labs's ROC % is -16.15% (calculated using TTM income statement data). Decipher Labs earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Decipher Labs  (BOM:524752) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Decipher Labs's WACC % is 17.83%. Decipher Labs's ROC % is -16.15% (calculated using TTM income statement data). Decipher Labs earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Decipher Labs ROC % Related Terms


Decipher Labs ROC % Historical Data

* Premium members only.

The historical data trend for Decipher Labs's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Decipher Labs ROC % Chart

Decipher Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.46 -6.98 -2.03 -37.31 -15.94

Decipher Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -92.99 -67.66 -0.03 -11.14 1.50
BOM:524752
57GF Score
Decipher Labs Ltd BOM:524752
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Decipher Labs ROC % Calculation

Decipher Labs's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2026 is calculated as:

ROC % (A: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2025 ) + Invested Capital (A: Mar. 2026 ))/ count )
=-39.058 * ( 1 - 16.3% )/( (202.999 + 207.273)/ 2 )
=-32.691546/205.136
=-15.94 %

where

Decipher Labs's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=3.116 * ( 1 - 0% )/( (0 + 207.273)/ 1 )
=3.116/207.273
=1.50 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 1.50% mean?
Decipher Labs (BOM:524752) has a ROC % of 1.50% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Decipher Labs and its competitors.
Is Decipher Labs' ROC % too high?
Decipher Labs' current ROC % is 1.50%. The Drug Manufacturers industry median ROC % is 4.46. Decipher Labs' value of 1.50% is 66.4% below this industry median. Overall, Decipher Labs has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Decipher Labs' ROC % compare to ZTS and UTHR?
Decipher Labs' ROC % of 1.50% can be compared against companies in the Drug Manufacturers industry. The industry median ROC % is 4.46. Decipher Labs' value of 1.50% is 66.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Drug Manufacturers company?
The median ROC % among Drug Manufacturers companies is 4.46, based on 988 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Decipher Labs's current ROC % of 1.50% is 66.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Decipher Labs and its competitors. For the Drug Manufacturers industry, the median ROC % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Decipher Labs's current ROC % is 1.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Decipher Labs stock overvalued right now?
Based on GuruFocus' analysis, Decipher Labs (BOM:524752) is currently considered Fairly Valued. The stock's GF Value™ is ₹6.34, compared to a current price of ₹6.29 — trading 0.8% below its estimated fair value. The current ROC % is 1.50% and 66.4% below the Drug Manufacturers industry median of 4.46. Decipher Labs' overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Decipher Labs (BOM:524752), the current ROC % is 1.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Decipher Labs (BOM:524752) Overvalued in 2026?

Based on GuruFocus' analysis, Decipher Labs stock appears to be undervalued. The current stock price of ₹6.29 is trading 0.8% below its estimated GF Value™ of ₹6.34. GuruFocus considers Decipher Labs to be Fairly Valued.

Key valuation signals for BOM:524752:

  • ROC %: 1.50%
  • GF Value™: ₹6.34 vs. price of ₹6.29 (0.8% below fair value)
  • GF Score™: 57/100 with 3 warning signs
  • Industry Position: 66.4% below the Drug Manufacturers median

No single metric tells the full story. See the BOM:524752 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Decipher Labs Business Description

Address Hitech City, A-2, Q2, 5th Floor, Cyber Towers, Madhapur, Hyderabad, TG, IND, 500081
Decipher Labs Ltd deals in the trading and manufacturing of Pharmaceutical drugs and allied products and services, and also offers services and key solutions in the Information Technology industry. It is involved in the manufacturing and marketing of its branded pharmaceutical products, and also provides drug development and manufacturing services to various formulators, manufacturers, and Research and Development agencies for their bulk needs. The group's IT Consultancy offerings include Technology Integration and Systems Consulting, Software Development Consulting, and Management of IT projects. Its reportable operating segments are: Pharmaceutical, which generates the maximum revenue, and IT Consultancy Services. Geographically, the group derives its key revenue from India.
57GF Score

Get the complete analysis for BOM:524752

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6.29
Price
₹6.34
GF Value